ArticlePloS one2025
Enhancing diabetes risk prediction through focal active learning and machine learning models.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer.Frontiers in medicine · 2026Article
- From raw data to actionable insights: preprocessing real-world data for machine learning in diabetes care.Frontiers in digital health · 2026Article
- Machine learning screening of risk factors for diabetic microvascular complications and construction of a gradient boosting decision tree predictive model.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To improve the effectiveness of diabetes risk prediction, this study proposes a novel method based on focal active learning strategies combined with machine learning models. Existing machine learning models often suffer from poor performance on imbalanced medical datasets, where minority class instances such as diabetic cases are underrepresented. Our proposed Focal Active Learning method selectively samples informative instances to mitigate this imbalance, leading to better prediction outcomes with fewer labeled samples. The method integrates SHAP (SHapley Additive Explanations) to quantify feature importance and applies attention mechanisms to dynamically adjust feature weights, enhancing model interpretability and performance in predicting diabetes risk. To address the issue of imbalanced classification in diabetes datasets, we employed a clustering-based method to identify representative data points (called foci), and iteratively constructed a smaller labeled dataset (sub-pool) around them using similarity-based sampling. This method aims to overcome common challenges, such as poor performance on minority classes and limited generalization, by enabling more efficient data utilization and reducing labeling costs. The experimental results demonstrated that our approach significantly improved the evaluation metrics for diabetes risk prediction, achieving an accuracy of 97.41% and a recall rate of 94.70%, clearly outperforming traditional models that typically achieve 95% accuracy and 92% recall. Additionally, the model's generalization ability was further validated on the public PIMA Indians Diabetes DataBase, outperforming traditional models in both accuracy and recall. This approach can enhance early diabetes screening in clinical settings, helping healthcare professionals reduce diagnostic errors and optimize resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.